- Home
- EOSE vs BHVN Comparison
EOSE vs BHVN Comparison
Compare EOSE & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOSE
- BHVN
- Stock Information
- Founded
- EOSE 2008
- BHVN 2013
- Country
- EOSE United States
- BHVN United States
- Employees
- EOSE N/A
- BHVN N/A
- Industry
- EOSE Industrial Machinery/Components
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- EOSE Miscellaneous
- BHVN Health Care
- Exchange
- EOSE Nasdaq
- BHVN Nasdaq
- Market Cap
- EOSE 1.5B
- BHVN 1.4B
- IPO Year
- EOSE N/A
- BHVN 2017
- Fundamental
- Price
- EOSE $5.51
- BHVN $14.73
- Analyst Decision
- EOSE Strong Buy
- BHVN Strong Buy
- Analyst Count
- EOSE 3
- BHVN 14
- Target Price
- EOSE $6.50
- BHVN $58.85
- AVG Volume (30 Days)
- EOSE 15.9M
- BHVN 1.9M
- Earning Date
- EOSE 07-30-2025
- BHVN 08-11-2025
- Dividend Yield
- EOSE N/A
- BHVN N/A
- EPS Growth
- EOSE N/A
- BHVN N/A
- EPS
- EOSE N/A
- BHVN N/A
- Revenue
- EOSE $33,800,000.00
- BHVN N/A
- Revenue This Year
- EOSE $945.82
- BHVN N/A
- Revenue Next Year
- EOSE $195.86
- BHVN $1,007.82
- P/E Ratio
- EOSE N/A
- BHVN N/A
- Revenue Growth
- EOSE 128.49
- BHVN N/A
- 52 Week Low
- EOSE $1.40
- BHVN $12.79
- 52 Week High
- EOSE $7.36
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- EOSE 50.60
- BHVN 52.18
- Support Level
- EOSE $5.79
- BHVN $12.79
- Resistance Level
- EOSE $6.55
- BHVN $16.00
- Average True Range (ATR)
- EOSE 0.52
- BHVN 0.98
- MACD
- EOSE -0.03
- BHVN 0.22
- Stochastic Oscillator
- EOSE 37.50
- BHVN 60.28
About EOSE Eos Energy Enterprises Inc.
Eos Energy Enterprises Inc designs develop, manufactures, and markets zinc-based energy storage solutions for utility-scale, microgrid, and commercial & industrial (C&I) applications. The solutions are used in the utility sector, the renewable energy sector, and the industrial sector. It's flagship product Eos Znyth is a stationary battery energy storage system.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.